Home/ Supplements/ Omega 3/ Osteo Bi-Flex Joint & OmegaCare

Osteo Bi-Flex Joint & OmegaCare

product on market Softgel Capsule Osteo Bi-Flex Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 38% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This product contains fish oil, which is supported by strong evidence for reducing joint inflammation and supporting cardiovascular health. Other listed components are basic macronutrients that provide general nutritional support. Overall, the evidence coverage for this specific ingredient profile is very limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Osteo Bi-Flex Joint & OmegaCare
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Softgel(s)
Serving Size
40
Servings
Other Combinations
Product Type
38%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
15 Calorie(s)
Total Fat
1.5 Gram(s) (2% DV)
Cholesterol
10 mg (3% DV)
Protein
1 Gram(s) (2% DV)
1200 mg
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
1500 mg
Market median: 1000.0mg (1115 products) 24 studies (A:0, B:9)
Market median: 375.0mg (171 products) 31 studies (A:1, B:14)
Market median: 100.0mg (173 products)

Other Ingredients

Gelatin Glycerin Soybean Oil Contains <2% of:
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

3 per day

Directions For Adult Use: Take three (3) softgels per day preferably with food. As a reminder, discuss the supplements and medications you take with your health care providers. Note: You have the option of taking three softgels together or spread throughout the day.

Warnings & Precautions

Contain soy, fish (sardine, anchovy, mackerel) and shellfish (shrimp, crab) ingredients

Keep out of reach of children.

Tamper Resistant: Do not use if seal under cap is broken or missing.

Caution: If you are pregnant, nursing, taking any medications, planning any medical procedure or have any medical condition consult your doctor before use.

Discontinue use and consult your doctor if any adverse reactions occur.

Not intended for use by persons under the age of 18.

Formulation Notes

With 5-Loxin advanced Joint & OmegaCare Glucosamine

Contain soy, fish (sardine, anchovy, mackerel) and shellfish (shrimp, crab) ingredients

Add Osteo Bi-Flex Joint & OmegaCare to your joint care regimen, it contains 1,500 mg of Glucosamine, a key building block of cartilage. With the addition of our Joint Shield proprietary blend which contains MSM, Fish Oil and 5-Loxin Advanced, this revolutionary formula helps lubricate your joints and has the added benefit of helping maintain a healthy heart.

Additional Information

The natural aging process can add excessive stress on your joints. Annoying flare-ups can strike at any time.

Store at room temperature and avoid excessive heat.

31573 04E B32885 DAC

Metadata

Product Details

UPC / SKU0 30768 31573 3
DSLD Entry Date2017-04-25
Product TypeOther Combinations
FormSoftgel Capsule
DSLD ID72909
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.